Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-037270
Filing Date
2020-06-17
Accepted
2020-06-17 16:29:17
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4028
  Complete submission text file 0001209191-20-037270.txt   5478
Mailing Address THERAVANCE,INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Mammen Mathai (Reporting) CIK: 0001421050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39035 | Film No.: 20970048

Mailing Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588
Business Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 (925) 401-7300
10x Genomics, Inc. (Issuer) CIK: 0001770787 (see all company filings)

EIN.: 455614458 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments